Qualigen Therapeutics, Inc is a biotechnology business based in the US. Qualigen Therapeutics shares (QLGN) are listed on the NASDAQ and all prices are listed in US Dollars. Qualigen Therapeutics employs 34 staff and has a trailing 12-month revenue of around 0.00.
How to buy shares in Qualigen Therapeutics
- Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – QLGN – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Qualigen Therapeutics stock price (NASDAQ: QLGN)Use our graph to track the performance of QLGN stocks over time.
Qualigen Therapeutics shares at a glance
|Latest market close||$1.91|
|52-week range||$1.51 - $6.18|
|50-day moving average||$1.95|
|200-day moving average||$2.56|
|Wall St. target price||$9.75|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-0.63|
Buy Qualigen Therapeutics shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Qualigen Therapeutics stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Qualigen Therapeutics price performance over time
|1 week (2021-07-22)||N/A|
|1 month (2021-07-02)||-2.05%|
|3 months (2021-04-30)||-11.16%|
|6 months (2021-01-29)||N/A|
|1 year (2020-07-29)||N/A|
|2 years (2019-07-29)||N/A|
|3 years (2018-07-29)||N/A|
|5 years (2016-07-29)||N/A|
Qualigen Therapeutics financials
|Revenue TTM||$4.2 million|
|Gross profit TTM||$-2,675,581|
|Return on assets TTM||-42.52%|
|Return on equity TTM||-237%|
|Market capitalisation||$50.5 million|
TTM: trailing 12 months
Shorting Qualigen Therapeutics shares
There are currently 1.7 million Qualigen Therapeutics shares held short by investors – that's known as Qualigen Therapeutics's "short interest". This figure is 4.6% up from 1.7 million last month.
There are a few different ways that this level of interest in shorting Qualigen Therapeutics shares can be evaluated.
Qualigen Therapeutics's "short interest ratio" (SIR)
Qualigen Therapeutics's "short interest ratio" (SIR) is the quantity of Qualigen Therapeutics shares currently shorted divided by the average quantity of Qualigen Therapeutics shares traded daily (recently around 300576.94974003). Qualigen Therapeutics's SIR currently stands at 5.77. In other words for every 100,000 Qualigen Therapeutics shares traded daily on the market, roughly 5770 shares are currently held short.
However Qualigen Therapeutics's short interest can also be evaluated against the total number of Qualigen Therapeutics shares, or, against the total number of tradable Qualigen Therapeutics shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Qualigen Therapeutics's short interest could be expressed as 0.06% of the outstanding shares (for every 100,000 Qualigen Therapeutics shares in existence, roughly 60 shares are currently held short) or 0.0652% of the tradable shares (for every 100,000 tradable Qualigen Therapeutics shares, roughly 65 shares are currently held short).
A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against Qualigen Therapeutics.
Find out more about how you can short Qualigen Therapeutics stock.
Qualigen Therapeutics share dividends
We're not expecting Qualigen Therapeutics to pay a dividend over the next 12 months.
Have Qualigen Therapeutics's shares ever split?
Qualigen Therapeutics's shares were split on a 1:25 basis on 25 May 2020. So if you had owned 25 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Qualigen Therapeutics shares – just the quantity. However, indirectly, the new 2400% higher share price could have impacted the market appetite for Qualigen Therapeutics shares which in turn could have impacted Qualigen Therapeutics's share price.
Qualigen Therapeutics overview
Qualigen, Inc. , a biotechnology company, develops novel therapeutic products for the treatment of cancer and infectious diseases. It offers FastPack, a rapid diagnostic testing system; ALAN, a DNA coated gold nanoparticle cancer drug candidate that targets various cancers; AS1411 for treating viral-based infectious diseases; RAS-F3, a small-molecule RAS oncogene protein-protein inhibitor that blocks RAS mutations and inhibits tumor formation; and STARS blood cleansing system, a DNA/RNA-based treatment device that removes tumor-produced compounds and viruses from a patient's blood. Qualigen, Inc. was founded in 1996 and is based in Carlsbad, California. .
Stocks similar to Qualigen Therapeutics
Qualigen Therapeutics in the news
Qualigen Therapeutics, Inc. Announces Submission of Investigational New Drug (IND) Application for QN-165, for the Treatment of COVID-19
Qualigen Files US Application To Start Human Trials For COVID-19 Candidate
Qualigen Therapeutics Submits Application for QN-165 in Covid-19; Shares Rise
Frequently asked questionsWhat percentage of Qualigen Therapeutics is owned by insiders or institutions?
Currently 10.644% of Qualigen Therapeutics shares are held by insiders and 6.639% by institutions. How many people work for Qualigen Therapeutics?
Latest data suggests 34 work at Qualigen Therapeutics. When does the fiscal year end for Qualigen Therapeutics?
Qualigen Therapeutics's fiscal year ends in December. Where is Qualigen Therapeutics based?
Qualigen Therapeutics's address is: 2042 Corte Del Nogal, Carlsbad, CA, United States, 92011 What is Qualigen Therapeutics's ISIN number?
Qualigen Therapeutics's international securities identification number is: US74754R1032
More guides on Finder
How to buy Argus Capital Corp (ARGU) stock when it goes public
Everything we know about the Argus Capital Corp IPO, plus information on how to buy in.
How to buy RenovoRx (RNXT) stock when it goes public
Everything we know about the RenovoRx IPO, plus information on how to buy in.
How to buy Draganfly (DPRO) stock when it goes public
Everything we know about the Draganfly IPO, plus information on how to buy in.
How to buy Society Pass Incorporated (SOPA) stock when it goes public
Everything we know about the Society Pass Incorporated IPO, plus information on how to buy in.
How to buy Guardforce AI Co (GFAI) stock when it goes public
Everything we know about the Guardforce AI Co IPO, plus information on how to buy in.
How to buy IsoPlexis Corporation (ISO) stock when it goes public
Everything we know about the IsoPlexis Corporation IPO, plus information on how to buy in.
How to buy Marpai (MRAI) stock when it goes public
Everything we know about the Marpai IPO, plus information on how to buy in.
How to buy DoubleDown Interactive (DDI) stock when it goes public
Everything we know about the DoubleDown Interactive IPO, plus information on how to buy in.
How to buy Omniq Corp (OMQS) stock when it goes public
Everything we know about the Omniq Corp IPO, plus information on how to buy in.
How to buy Mechanical Technology (MKTYP) stock when it goes public
Everything we know about the Mechanical Technology IPO, plus information on how to buy in.
Ask an Expert